지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 거트앤리버 발행위원회 Gut and Liver Gut and Liver 제13권 제6호 KCI등재 SCOPUS
- 발행연도
- 2019.1
- 수록면
- 604 - 616 (13page)
이용수
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
초록· 키워드
오류제보하기
New therapeutic strategies in inflammatory bowel disease (IBD) have shifted from symptom control towards treat-totarget algorithms in order to optimize treatment results. The treatment of IBD has evolved with the development of tumor necrosis factor-α inhibitors beyond the conventional therapies. In spite of their long-term effectiveness, many patients do not respond to or cannot sustain treatment with these drugs, which have various side effects. Therefore, the development of new drugs targeting specific pathways in the pathogenesis of IBD has become necessary. Some novel biologics and small molecule drugs have shown potential in IBD clinical trials, providing safe and effective results. In addition, clinicians are now trying to target the dysbiotic microbiome of patients with IBD using fecal microbiota transplantation. New tools such as stem cells have also been developed. The available therapeutic options for IBD are expanding rapidly. In the next few years, physicians will face an unprecedented number of options when choosing the best treatments for patients with IBD. This review provides an overview of recent advances in IBD treatment options.
목차
등록된 정보가 없습니다.
참고문헌 (100)
참고문헌 신청
Burger D / 2011 / Conventional medical management of inflammatory bowel disease / Gastroenterology 140:1827~1837
Rutgeerts P / 2005 / Infliximab for induction and maintenance therapy for ulcerative colitis / N Engl J Med 353:2462~2476
Reinisch W / 2011 / Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis : results of a randomised controlled trial / Gut 60:780~787
Sandborn WJ / 2012 / Adalimumab induces and maintains clinical remission in patients with moderateto-severe ulcerative colitis / Gastroenterology 142:257~265
Targan SR / 1997 / A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease / N Engl J Med 337:1029~1035
Rutgeerts P / 2005 / Infliximab for induction and maintenance therapy for ulcerative colitis / N Engl J Med 353:2462~2476
Reinisch W / 2011 / Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis : results of a randomised controlled trial / Gut 60:780~787
Sandborn WJ / 2012 / Adalimumab induces and maintains clinical remission in patients with moderateto-severe ulcerative colitis / Gastroenterology 142:257~265
Targan SR / 1997 / A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease / N Engl J Med 337:1029~1035
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
Gut and Liver
2020 .01
-
Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
Intestinal research
2023 .04
-
Immunological pathogenesis of inflammatory bowel disease
Intestinal research
2018 .01
-
Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study
Gut and Liver
2017 .07
-
우리나라 염증장질환의 현황
대한의사협회지
2021 .09
-
Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
Intestinal research
2022 .10
-
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
Immune Network
2017 .02
-
Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
대한류마티스학회지
2020 .01
-
Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists
Pediatric Gastroenterology, Hepatology & Nutrition
2020 .01
-
Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
Intestinal research
2022 .04
-
Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models
Intestinal research
2020 .01
-
Erratum: Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization for Crohn’s and Colitis (AOCC) meeting in Seoul
Intestinal research
2016 .01
-
Surgical Strategies of Pediatric IBD through Adult IBD (I): UC
대한외과학회 학술대회 초록집
2022 .11
-
염증장질환의 역학 및 진단
대한의사협회지
2021 .09
-
Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study
Gut and Liver
2020 .01
-
Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn’s and Colitis (AOCC) meeting in Seoul
Intestinal research
2016 .01
-
Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea
Intestinal research
2016 .01
-
Gastritis Associated with Initially Pediatric Crohn’s Disease andUlcerative Colitis
Pediatric Gastroenterology, Hepatology & Nutrition
2018 .01
-
Surgical Strategies of Pediatric IBD through Adult IBD (II): Crohn disease
대한외과학회 학술대회 초록집
2022 .11
-
Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life
Gut and Liver
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
첫번째 댓글을 남겨주세요.